Thursday, 10 January 2013

United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018: ResearchMoz


ResearchMoz.us include new market research report"United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018" to its huge collection of research reports.United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the United Arab Emirates In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Directs team of industry experts.
Scope

- Market size and company share data for In Vitro Diagnostics market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the United Arab Emirates In Vitro Diagnosticsmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Beckman Coulter, Inc., Abbott Laboratories, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United Arab Emirates In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table Of Contenct
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 122.1 What is This Report About? 12
3 In Vitro Diagnostics In United Arab Emirates 133.1 In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018 13
3.2 In Vitro Diagnostics, United Arab Emirates, Company Share (2010-2011) 19
4 Clinical Chemistry In United Arab Emirates 214.1 Clinical Chemistry Overall Revenue, (2004-2018) 21
4.1.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 25
4.1.2 Urine Analysis, Revenue (2004-2018) 29
4.2 Clinical Chemistry Distribution Share (2010-2011) 33
4.3 Clinical Chemistry, United Arab Emirates, Company Share (2010-2011) 34
5 Genetic Testing In United Arab Emirates 365.1 Genetic Testing Overall Revenue, (2004-2018) 36
5.2 Genetic Testing Distribution Share (2010-2011) 40
5.3 Genetic Testing, United Arab Emirates, Company Share (2010-2011) 41
6 Haematology In United Arab Emirates 436.1 Haematology Overall Revenue, (2004-2018) 43
6.1.1 Haematology Reagents, Revenue, (2004-2018) 47
6.1.2 Immunohaematology, Revenue (2004-2018) 51
6.1.3 Haemostasis, Revenue (2004-2018) 55
6.1.4 Haematology Rapid Tests, Revenue (2004-2018) 59
6.1.5 Haematology Cell Counters, Revenue (2004-2018) 63
6.2 Haematology Distribution Share (2010-2011) 67
6.3 Haematology, United Arab Emirates, Company Share (2010-2011) 68
For More Info, Please Visit@ http://www.researchmoz.us/united-arab-emirates-in-vitro-diagnostics-investment-opportunities-analysis-and-forecasts-to-2018-report.html

7 Histology And Cytology In United Arab Emirates 707.1 Histology And Cytology Overall Revenue, (2004-2018) 70
7.2 Histology And Cytology Distribution Share (2010-2011) 74
7.3 Histology And Cytology, United Arab Emirates, Company Share (2010-2011) 75
8 Immuno Chemistry In United Arab Emirates 778.1 Immuno Chemistry Overall Revenue, (2004-2018) 77
8.1.1 Disease Specific Immunochemistry, Revenue (2004-2018) 81
8.1.2 Drugs of Abuse / Toxicology, Revenue (2004-2018) 85
8.1.3 Endocrinology Tests, Revenue (2004-2018) 88
8.1.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 92
8.1.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 96
8.1.6 Immunochemistry Analyzers, Revenue (2004-2018) 100
8.2 Immuno Chemistry Distribution Share (2010-2011) 104
8.3 Immuno Chemistry, United Arab Emirates, Company Share (2010-2011) 105
9 Infectious Immunology In United Arab Emirates 1079.1 Infectious Immunology Overall Revenue, (2004-2018) 107
9.1.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 111
9.2 Infectious Immunology Distribution Share (2010-2011) 115
9.3 Infectious Immunology, United Arab Emirates, Company Share (2010-2011) 116
10 Microbiology Culture In United Arab Emirates 11810.1 Microbiology Culture Overall Revenue, (2004-2018) 118
10.1.1 Microbiology Analyzers, Revenue (2004-2018) 122
10.2 Microbiology Culture Distribution Share (2010-2011) 126
10.3 Microbiology Culture, United Arab Emirates, Company Share (2010-2011) 127
For All Latest Market Research Reports@ http://www.researchmoz.us/report.html

11 Overview of Key Companies in United Arab Emirates In Vitro Diagnostics Market 12911.1 F. Hoffmann-La Roche Ltd. 129
11.1.1 Company Overview 129
11.2 Siemens Healthcare 129
11.2.1 Company Overview 129
11.3 Beckman Coulter, Inc. 130
11.3.1 Company Overview 130
11.4 Abbott Laboratories 130
11.4.1 Company Overview 130
11.5 Ortho-Clinical Diagnostics Inc. 131
11.5.1 Company Overview 131
11.6 bioMerieux S.A. 131
11.6.1 Company Overview 131
11.7 ELITech Group 132
11.7.1 Company Overview 132
11.8 Becton, Dickinson and Company 132
11.8.1 Company Overview 132
11.9 Alere Inc. 133
11.9.1 Company Overview 133
11.10 Mindray Medical International Limited 133
11.10.1 Company Overview 133
11.11 Bio-Rad Laboratories, Inc. 134
11.11.1 Company Overview 134
11.12 PerkinElmer, Inc. 134
11.12.1 Company Overview 134
11.13 Sysmex Corporation 135
11.13.1 Company Overview 135
11.14 Thermo Fisher Scientific Inc. 135
11.14.1 Company Overview 135
11.15 Horiba, Ltd. 136
11.15.1 Company Overview 136
11.16 Grifols, S.A. 136
11.16.1 Company Overview 136
11.17 DiaSorin S.p.A 137
11.17.1 Company Overview 137
11.18 Qiagen N.V. 137
11.18.1 Company Overview 137
11.19 Gen-Probe Incorporated 138
11.19.1 Company Overview 138
11.20 Diagnostica Stago, Inc. 138
11.20.1 Company Overview 138
11.21 Life Technologies Corporation 139
11.21.1 Company Overview 139
11.22 Hologic, Inc. 139
11.22.1 Company Overview 139
11.23 Immucor, Inc. 140
11.23.1 Company Overview 140
11.24 Chembio Diagnostics, Inc. 140
11.24.1 Company Overview 140
11.25 Phadia AB 140
11.25.1 Company Overview 140
12 Appendix 141
12.1 Global Markets Direct Research Methodology 141
12.2 Definitions of Markets Covered in the Report 142
12.2.1 In Vitro Diagnostics 142
12.3 Secondary Research 153
12.4 Primary Research 153
12.5 Models 154
12.6 Forecasts 154
12.7 Expert Panel Validation 154
12.8 Currency Conversion 155
12.9 Contact Us 155
12.10 Disclaimer 155
Find us on:
cid:image001.gif@01CDE37F.C969D380cid:image002.gif@01CDE37F.C969D380cid:image003.gif@01CDE37F.C969D380cid:image004.gif@01CDE37F.C969D380cid:image005.gif@01CDE37F.C969D380images

No comments:

Post a comment